EMPLOYMENT AGREEMENTEmployment Agreement • October 29th, 2020 • Oracle Health, Inc. • Delaware
EMPLOYMENT AGREEMENT (this “Employment Agreement”), dated as of January 1, 2020, between Oracle Health, Inc., a Delaware corporation (the “Company”), and Jaeson Bang, an individual (the “Executive”).
OFFERING LISTING AGREEMENTOffering Listing Agreement • October 29th, 2020 • Oracle Health, Inc. • New York
This Offering Listing Agreement (this “Agreement”) is effective this August 17, 2020 (the “Effective Date”) by and among ORACLE HEALTH, INC. (Company Name), a Delaware C-Corp (“Issuer”), and OpenDeal Broker LLC dba the Capital R (“ODB”), a New York limited liability company corporation. Issuer and ODB are hereby referred to collectively as the “Parties” or individually as a “Party”.
ContractOracle Health, Inc. • October 29th, 2020 • Delaware
THIS INSTRUMENT AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE ACT. FOR ONE YEAR FROM THE DATE OF THIS INSTRUMENT, SECURITIES SOLD IN RELIANCE ON REGULATION CROWDFUNDING UNDER THE ACT MAY ONLY BE TRANSFERRED TO THE COMPANY, TO AN “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501 OF REGULATION D UNDER THE ACT, AS PART OF AN OFFERING REGISTERED UNDER THE SECURITIES ACT WITH THE SEC, OR TO A MEMBER OF INVESTOR’S FAMILY OR THE EQUIVALENT, TO A TRUST CONTROLLED BY THE INVESTOR, TO A TRUST CREATED FOR THE BENEFIT OF A MEMBER OF THE FAMILY OF THE INVESTOR OR EQUIVALENT, OR IN CONNECTION WITH THE DEATH OR DIVORCE OF THE INVESTOR OR OTHER SIMILAR CIRCUMSTANCE. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY,
SUBSCRIPTION AGREEMENT ORACLE HEALTH, INC. Regulation ASubscription Agreement • October 29th, 2020 • Oracle Health, Inc. • Florida
This Subscription Agreement (this “Agreement”) is made between Oracle Health, Inc. (the “Company”) and the investor executing this Agreement (the “Investor”). Pursuant to terms and conditions of this Subscription Agreement, and subject to its terms and conditions, the Company agrees to sell to the Investor, and the Investor agrees to purchase, that certain number of shares representing a $[ ] investment previously specified by the Investor to the Company (the “Shares”) of the Company’s common stock, par value of $0.00001 per share, relating to the exempt offering by the Company (the “Offering”) for up to 4,000,000 shares of the Company’s common stock for aggregate maximum gross proceeds of $8,000,000. The purchase price of such Shares is $2.00 per share.
Research Collaboration AgreementResearch Collaboration Agreement • October 29th, 2020 • Oracle Health, Inc.
● OH develops, manufactures and markets state of the art technology in the field of cardiac monitoring for application in the medical sector;
LICENSE AGREEMENTLicense Agreement • October 29th, 2020 • Oracle Health, Inc. • Texas
This License Agreement (the “Agreement”) is made as of the 18th of NOVEMBER , 2019, between Texas Medical Center, a Texas non-profit corporation, as Licensor (the “Licensor”), and ORACLE HEALTH, INC., as Licensee (the “Licensee”).
TMCx ACCELERATOR PROGRAM PARTICIPATION AGREEMENTTMCX Accelerator • October 29th, 2020 • Oracle Health, Inc. • Texas
This TMCx Accelerator Program Participation Agreement (the “Agreement”) is entered into as of the Effective Date (defined below) between Texas Medical Center, a Texas non-profit corporation (“TMC”) and Participant (defined below). TMC and Participant are each sometimes referred to as a “Party” and collectively as the “Parties”.
